Cai Shang,Tian Ye,Xu Bo.Recent progress in the combination treatment of radiotherapy and PD-1/PD-L1 signaling blockade immunotherapy[J].Chinese Journal of Radiological Medicine and Protection,2016,36(3):235-240
Recent progress in the combination treatment of radiotherapy and PD-1/PD-L1 signaling blockade immunotherapy
Received:September 29, 2015  
DOI:10.3760/cma.j.issn.0254-5098.2016.03.015
KeyWords:Radiotherapy  PD-1/PD-L1 signal blockade  Oncology immunotherapy
FundProject:
Author NameAffiliationE-mail
Cai Shang Department of Radiotherapy & Oncology, Second Affiliated Hospital of Soochow University, Institute of Radiotherapy & Oncology, Soochow University, Suzhou Key Laboratory for Radiation Oncology, Suzhou 215004, China  
Tian Ye Department of Radiotherapy & Oncology, Second Affiliated Hospital of Soochow University, Institute of Radiotherapy & Oncology, Soochow University, Suzhou Key Laboratory for Radiation Oncology, Suzhou 215004, China  
Xu Bo Department of Oncology, Southern Research Institute, Birmingham, AL 35205, USA bxu@uab.edu 
Hits: 2773
Download times: 2447
Abstract::
      Every stage of tumor initiation and development closely relates to immune regulation as tumor cells tend to evade attacks from immune system by employing the programmed death 1 (PD-1)/programmed death-ligand 1 (PD-L1) interaction. Therefore, targeting the PD-1/PD-L1 pathway has become an attractive approach for cancer immunotherapy. Radiotherapy has long been considered a local tumor treatment modality and it is immune-inhibitory. However, accumulated evidence has shown that radiotherapy might enhance immune function by eliminating the tumor mass and has become a systemic tumor treatment modality. These observations indicate a strong rationale that the radiotherapy and anti-PD-1 and anti-PD-L1 immunotherapy may work synergistically to provide a powerful anti-tumor effect. This review discusses current progresses, challenges and perspectives of this novel combination treatment modality.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9078085  On-line:0

v
Scan QR Code
&et=2E527C7CBE5248A868816B88402F023D1B5E3723EBDF543A00E652D44D94A3BA13044B268754883CE37D6EBE60FD9527ABF556677FA3A0F05499C9512E562E311EDD7197B249D3BC620338F38A46984580D65654CF8334C19B09AC1232D1115B522A4E9B11A992CD9E6E72BEFE73ED9F&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=9F915C6F01DE79C5&aid=5CD45E0A11404E167DF3A4B9019A6CC6&vid=&iid=38B194292C032A66&sid=6CCE24D86D03D083&eid=C812B90E96151014&fileno=20160315&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="9F915C6F01DE79C5"; var my_aid="5CD45E0A11404E167DF3A4B9019A6CC6";